Biologic response-modifying agents: What is an appropriate phase I?II strategy?

Publisher Website

1 August 1980

journal article
Published by Springer Nature in Cancer Immunology, Immunotherapy

Vol. 8 (4)
https://doi.org/10.1007/bf00206036

Abstract

No abstract available

Keywords

Cited by 7 articles